$kavl - worth paying attention to

4 sie 2020KAVL has been having a sort of pre-news / event capitulation once a month since releasing revenues for the first time in april. that event appeared to have happened yesterday and with the quarter ending on july 31 we can expect news in the coming week, maybe two. also worth noting is after approaching the 50DMA KAVL tends to run.

Fundamentals
Positive Earnings last quarter - 22M rev and 4M profit w/ 2 distribution channels
June / July KAVL uplisted to the OTCQB and price increased from roughly $0.50 to 1.00

News for this quarter not yet priced in:
1 Distribution channels have grown from 2 to 8
2 International Distribution to New Zealand and the UK
3 FDA approved product (1 of very few)

With increased distribution rev and earnings should at a minimum double.

otcmarkets.com/stock/KAVL/disclosure

18 sie 2020

Komentarz

Earnings due out anytime. Retraced to the 50DMA last week and bounced hard as it has several time prior to news and earnings this year.